Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses

被引:0
|
作者
Yachida, Junko [1 ,2 ]
Fujihara, Kazuya [1 ]
Yamada, Mayuko Harada [1 ]
Kobayashi, Ayako [1 ,2 ]
Khin, Lay Mon [1 ]
Takizawa, Hiroki [1 ]
Yamamoto, Masahiko [1 ]
Kitazawa, Masaru [1 ]
Matsubayashi, Yasuhiro [1 ]
Yamada, Takaho [1 ]
Kodama, Satoru [1 ]
Sone, Hirohito [1 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan
[2] Niigata Coll Nursing, Joetsu, Japan
基金
日本学术振兴会;
关键词
cardiovascular disease; coronary artery disease; glucose abnormalities; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; STATIN-TREATED PATIENTS; APOLIPOPROTEIN-A-I; HEART-DISEASE; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; INSULIN-RESISTANCE; TOLERANCE STATUS; LDL CHOLESTEROL; MORTALITY; JAPAN;
D O I
10.1111/dom.15956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate the association between low-density lipoprotein-cholesterol (LDL-C) levels and coronary artery disease (CAD) incidence based on combining high-density lipoprotein-cholesterol (HDL-C) levels and glucose status. Materials and Methods: In this retrospective cohort study, we used data from a nationwide claims database (1,524,289 individuals without a history of CAD or familial hypercholesterolaemia; 2008-2019). Cox proportional hazards modelling identified the risk of incident CAD by a novel combination of four HDL-C levels, seven LDL-C levels and glucose status. Results: During the follow-up period (mean: 5.5 years), 8301 (0.99/1000 person-years) events occurred. The risk of CAD increased from lower LDL-C levels accompanied by lower HDL-C levels regardless of the glucose status. Using the most favourable levels of HDL-C and LDL-C (i.e. 60-99 mg/dL and <80 mg/dL, respectively) as references, the hazard ratios (95% confidence interval) for the group with HDL-C levels <40 mg/dL and LDL-C levels <80 mg/dL were 2.74 (1.47-5.11), 2.52 (1.30-4.91) and 2.85 (1.68-4.84) for normoglycaemia, borderline glycaemia and diabetes, respectively. Comparison of the most favourable levels of HDL-C and LDL-C with their least favourable levels (i.e. <40 mg/dL and 180-199 mg/dL, respectively) revealed that the risk of new-onset CAD exhibited a 19-, nine- and seven-fold increase in individuals with normoglycaemia, borderline glycaemia and diabetes, respectively. Conclusions: To prevent CAD, LDL-C levels should be strictly controlled in patients with low HDL-C levels regardless of glucose tolerance. Individualized treatment, which involves setting target LDL-C levels based on glucose tolerance and HDL-C values, is required.
引用
收藏
页码:5845 / 5856
页数:12
相关论文
共 50 条
  • [31] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Fonseca, Liliana
    Paredes, Silvia
    Ramos, Helena
    Oliveira, Jose Carlos
    Palma, Isabel
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [32] SERUM-CHOLESTEROL AND HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL IN CORONARY PATIENTS AND HEALTHY-PERSONS
    BRUNNER, D
    WEISBORT, J
    LOEBL, K
    SCHWARTZ, S
    ALTMAN, S
    BEARMAN, JE
    LEVIN, S
    ATHEROSCLEROSIS, 1979, 33 (01) : 9 - 16
  • [33] The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma
    Jiang, Shan-Shan
    Weng, De-Sheng
    Jiang, Long
    Zhang, Yao-Jun
    Pan, Ke
    Pan, Qiu-Zhong
    Chen, Chang-Long
    Zhao, Jing-Jing
    Zhang, Xiao-Fei
    Zhang, Hong-Xia
    Tang, Yan
    Zhou, Zi-Qi
    Chen, Min-Shan
    Xia, Jian-Chuan
    JOURNAL OF CANCER, 2016, 7 (06): : 626 - 632
  • [34] High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review
    Amarenco, Pierre
    Labreuche, Julien
    Touboul, Pierre-Jean
    ATHEROSCLEROSIS, 2008, 196 (02) : 489 - 496
  • [35] Association of triglycerides to high-density lipoprotein-cholesterol ratio with risk of incident hypertension
    Dechen Liu
    Li Guan
    Yang Zhao
    Yu Liu
    Xizhuo Sun
    Honghui Li
    Zhaoxia Yin
    Linlin Li
    Yongcheng Ren
    Bingyuan Wang
    Cheng Cheng
    Leilei Liu
    Xu Chen
    Qionggui Zhou
    Quanman Li
    Chunmei Guo
    Gang Tian
    Ming Zhang
    Dongsheng Hu
    Jie Lu
    Hypertension Research, 2020, 43 : 948 - 955
  • [36] Contemporary lipid clinic and achievements in low-density lipoprotein-cholesterol reductions in very high-risk patients
    Larsen, Jens V.
    Martinsen, Morten H.
    Mortensen, Martin B.
    Klausen, Ib C.
    Hedegaard, Berit S.
    DANISH MEDICAL JOURNAL, 2021, 68 (01):
  • [37] Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
    You, Jiayin
    Wang, Zhenhao
    Lu, Guoping
    Chen, Zhenyue
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [38] Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
    Hayashi, Toshiyuki
    Fukui, Tomoyasu
    Nakanishi, Noriko
    Yamamoto, Saki
    Tomoyasu, Masako
    Osamura, Anna
    Ohara, Makoto
    Yamamoto, Takeshi
    Ito, Yasuki
    Hirano, Tsutomu
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [39] Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease
    Yang, Sheng-Hua
    Du, Ying
    Li, Xiao-Lin
    Zhang, Yan
    Li, Sha
    Xu, Rui-Xia
    Zhu, Cheng-Gang
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Qing, Ping
    Gao, Ying
    Cui, Chuan-Jue
    Dong, Qian
    Sun, Jing
    Li, Jian-Jun
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 354 (02) : 117 - 124
  • [40] Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
    Jafari, Jamal
    Daum, Aner
    Abu Hamed, Jihad
    Osherov, Azriel
    Orlov, Yan
    Yosefy, Chaim
    Gallego-Colon, Enrique
    BIOMEDICINES, 2019, 7 (04)